Skip to main content
TCMD logo

TCMD · Tactile Systems Technology Inc · Webcasts, Transcripts & Audio

Track TCMD — free
$21.79 +0.08 (+0.37%) At close · Oct 2
Market Cap
$514.89M
Shares
22.65M
Volume · Oct 2 252.32K Avg daily vol (3M) 295.36K

Tactile Systems Technology Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Tactile Systems Technology Inc (TCMD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-08-10
Tactile Systems Technology Inc (TCMD) Q2 2026 Earnings Call
Revenue
$85.70M
▲ 8.6% YoY
Diluted EPS
$0.34
▲ 142.9% YoY
Gross margin
76.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-02
Tactile Systems Technology Inc (TCMD) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-04
Tactile Systems Technology Inc (TCMD) Q1 2026 Earnings Call Transcript
Confident tone Prior authorization transition for Medicare PCDs Lymphedema business growth and NCD tailwind Lymphotech acquisition integration
Revenue
$75.27M
▲ 22.8% YoY
Diluted EPS
$-0.08
Gross margin
76.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
Tactile Systems Technology Inc (TCMD) Q4 2025 Earnings Call Transcript
Confident tone 2026 financial outlook and guidance Lymphedema business momentum and commercial execution LymphaTech acquisition
Revenue
$103.59M*
▲ 21% YoY
Gross margin
78.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Tactile Systems Technology Inc (TCMD) Q3 2025 Earnings Call Transcript
Confident tone Lymphedema business recovery and growth Airway clearance / AffloVest momentum Flexitouch clinical evidence and payer engagement
Revenue
$85.75M
▲ 17.3% YoY
Diluted EPS
$0.36
▲ 71.4% YoY
Gross margin
75.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Tactile Systems Technology Inc (TCMD) Q2 2025 Earnings Call Transcript
Confident tone Lymphedema Business Performance Airway Clearance / AffloVest Growth CRM Implementation and Workflow Tools
Revenue
$78.91M
▲ 7.8% YoY
Diluted EPS
$0.14
▼ 22.2% YoY
Gross margin
74.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Tactile Systems Technology Inc (TCMD) Q1 2025 Earnings Call Transcript
Cautious tone Full-year guidance revision Lymphedema sales shortfall Salesforce CRM implementation
Revenue
$61.27M
▲ 0.3% YoY
Diluted EPS
$-0.13
Gross margin
74.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-18
Tactile Systems Technology Inc (TCMD) Q4 2024 Earnings Call Transcript
Positive tone Lymphedema business performance Patient leakage and DME documentation burden Technology modernization and CRM
Revenue
$85.58M*
▲ 10.2% YoY
Gross margin
75.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Tactile Systems Technology Inc (TCMD) Q3 2024 Earnings Call Transcript
Positive tone Medicare LCD documentation burden Lymphedema business performance Margin expansion and profitability
Revenue
$73.09M
▲ 5% YoY
Diluted EPS
$0.21
▼ 77.7% YoY
Gross margin
75.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Tactile Systems Technology Inc (TCMD) Q2 2024 Earnings Call Transcript
Confident tone Lymphedema Market Opportunity E-Prescribing / Order Acceleration Tool Leadership Transition & Strategy Refresh
Revenue
$73.22M
▲ 7.1% YoY
Diluted EPS
$0.18
Gross margin
73.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Tactile Systems Technology Inc (TCMD) Q1 2024 Earnings Call Transcript
Positive tone Lymphedema revenue growth Airway clearance / AffloVest Profitability and cash generation
Revenue
$61.09M
▲ 3.8% YoY
Diluted EPS
$-0.09
Gross margin
71.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Tactile Systems Technology Inc (TCMD) Q4 2023 Earnings Call Transcript
Positive tone Sales force productivity and expansion Airway clearance (AffloVest) dynamics Lymphedema product line growth
Revenue
$77.65M*
▲ 5.1% YoY
Gross margin
72.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Tactile Systems Technology Inc (TCMD) Q3 2023 Earnings Call Transcript
Revenue
$69.59M
▲ 6.6% YoY
Diluted EPS
$0.94
Gross margin
70.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Tactile Systems Technology Inc (TCMD) Q2 2023 Earnings Call Transcript
Revenue
$68.34M
▲ 14.6% YoY
Diluted EPS
$0.00
Gross margin
70.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Tactile Systems Technology Inc (TCMD) Q1 2023 Earnings Call Transcript
Revenue
$58.85M
▲ 22.7% YoY
Diluted EPS
$-0.09
Gross margin
70.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-21
Tactile Systems Technology Inc (TCMD) Q4 2022 Earnings Call Transcript
Revenue
$73.90M*
▲ 19.7% YoY
Gross margin
70.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Tactile Systems Technology Inc (TCMD) Q3 2022 Earnings Call Transcript
Revenue
$65.26M
▲ 24.3% YoY
Diluted EPS
$-0.11
Gross margin
71.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-01
Tactile Systems Technology Inc (TCMD) Q2 2022 Earnings Call Transcript
Revenue
$59.65M
▲ 16.8% YoY
Diluted EPS
$-0.23
▼ 428.6% YoY
Gross margin
72.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-02
Tactile Systems Technology Inc (TCMD) Q1 2022 Earnings Call Transcript
Revenue
$47.98M
▲ 12.2% YoY
Diluted EPS
$-0.78
Gross margin
70.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
Tactile Systems Technology Inc (TCMD) Q4 2021 Earnings Call Transcript
Revenue
$61.73M*
▲ 4.2% YoY
Gross margin
72.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Tactile Systems Technology Inc (TCMD) Q3 2021 Earnings Call Transcript
Revenue
$52.50M
▲ 6.9% YoY
Diluted EPS
$-0.17
▼ 241.7% YoY
Gross margin
70.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-02
Tactile Systems Technology Inc (TCMD) Q2 2021 Earnings Call Transcript
Revenue
$51.06M
▲ 45.4% YoY
Diluted EPS
$0.07
Gross margin
70.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-03
Tactile Systems Technology Inc (TCMD) Q1 2021 Earnings Call Transcript
Revenue
$42.77M
▼ 2.1% YoY
Diluted EPS
$-0.12
Gross margin
70.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-23
Tactile Systems Technology Inc (TCMD) Q4 2020 Earnings Call Transcript
Revenue
$59.24M
▲ 3.8% YoY
Diluted EPS
$0.61
▲ 177.3% YoY
Gross margin
70.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Tactile Systems Technology Inc (TCMD) Q3 2020 Earnings Call Transcript
Revenue
$49.09M
▼ 1% YoY
Diluted EPS
$0.12
▲ 0% YoY
Gross margin
71.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-03
Tactile Systems Technology Inc (TCMD) Q2 2020 Earnings Call Transcript
Revenue
$35.12M
▼ 22.3% YoY
Diluted EPS
$-0.72
▼ 614.3% YoY
Gross margin
70.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-04
Tactile Systems Technology Inc (TCMD) Q1 2020 Earnings Call Transcript
Revenue
$43.67M
▲ 16.1% YoY
Diluted EPS
$-0.07
▼ 187.5% YoY
Gross margin
71.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–27 of 27 webcasts
Key facts CIK 1027838 CUSIP 87357P100 13F (30d) 2 filings 2 filers Visit website Investor relations